Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Corrigendum to "Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition" [Heliyon 4 (7) (July 2018) e00707].

Fife D, Rep J, Cepeda MS, Stang P, Blacketer M, Singh J.

Heliyon. 2019 Mar 7;5(3):e01198. doi: 10.1016/j.heliyon.2019.e01198. eCollection 2019 Mar.

2.

Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.

Kubota K, Kamijima Y, Kao Yang YH, Kimura S, Chia-Cheng Lai E, Man KKC, Ryan P, Schuemie M, Stang P, Su CC, Wong ICK, Zhang Y, Setoguchi S.

PLoS One. 2018 Dec 12;13(12):e0208796. doi: 10.1371/journal.pone.0208796. eCollection 2018.

3.

Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges.

Lai EC, Ryan P, Zhang Y, Schuemie M, Hardy NC, Kamijima Y, Kimura S, Kubota K, Man KK, Cho SY, Park RW, Stang P, Su CC, Wong IC, Kao YY, Setoguchi S.

Clin Epidemiol. 2018 Jul 27;10:875-885. doi: 10.2147/CLEP.S149961. eCollection 2018.

4.

Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition.

Fife D, Reps J, Cepeda MS, Stang P, Blacketer M, Singh J.

Heliyon. 2018 Jul 26;4(7):e00707. doi: 10.1016/j.heliyon.2018.e00707. eCollection 2018 Jul. Erratum in: Heliyon. 2019 Mar 07;5(3):e01198.

5.
6.

Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.

Pazzagli L, Linder M, Zhang M, Vago E, Stang P, Myers D, Andersen M, Bahmanyar S.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):148-160. doi: 10.1002/pds.4372. Epub 2017 Dec 28. Review. Erratum in: Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):356.

7.

Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.

Cepeda MS, Reps J, Fife D, Blacketer C, Stang P, Ryan P.

Depress Anxiety. 2018 Mar;35(3):220-228. doi: 10.1002/da.22705. Epub 2017 Dec 15.

8.

Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study.

Yuan Z, DeFalco FJ, Ryan PB, Schuemie MJ, Stang PE, Berlin JA, Desai M, Rosenthal N.

Diabetes Obes Metab. 2018 Mar;20(3):582-589. doi: 10.1111/dom.13115. Epub 2017 Oct 11.

9.

Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.

Wang Y, Desai M, Ryan PB, DeFalco FJ, Schuemie MJ, Stang PE, Berlin JA, Yuan Z.

Diabetes Res Clin Pract. 2017 Jun;128:83-90. doi: 10.1016/j.diabres.2017.04.004. Epub 2017 Apr 13.

10.
12.

Seasonality in acute liver injury? Findings in two health care claims databases.

Weinstein RB, Schuemie MJ, Ryan PB, Stang PE.

Drug Healthc Patient Saf. 2016 Mar 31;8:39-48. doi: 10.2147/DHPS.S95399. eCollection 2016.

13.

Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005-2012.

Wang Y, Lopez JM, Bolge SC, Zhu VJ, Stang PE.

BMC Psychiatry. 2016 Apr 5;16:88. doi: 10.1186/s12888-016-0800-2.

14.

Changes in Body Weight Among People With Type 2 Diabetes Mellitus in the United States, NHANES 2005-2012.

Wang Y, Bolge SC, Lopez JM, Zhu VJ, Stang PE.

Diabetes Educ. 2016 Jun;42(3):336-45. doi: 10.1177/0145721716640096. Epub 2016 Mar 31.

PMID:
27033723
15.

Clinical Relevance of Sleep Duration: Results from a Cross-Sectional Analysis Using NHANES.

Cepeda MS, Stang P, Blacketer C, Kent JM, Wittenberg GM.

J Clin Sleep Med. 2016 Jun 15;12(6):813-9. doi: 10.5664/jcsm.5876.

16.

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.

Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Norén GN, Li YC, Stang PE, Madigan D, Ryan PB.

Stud Health Technol Inform. 2015;216:574-8.

17.

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.

Voss EA, Ryan PB, Stang PE, Hough D, Alphs L.

Int Clin Psychopharmacol. 2015 May;30(3):151-7. doi: 10.1097/YIC.0000000000000068.

18.

Authors' reply to Hennessy and Leonard's comment on "Desideratum for evidence-based epidemiology".

Overhage JM, Ryan PB, Schuemie MJ, Stang PE.

Drug Saf. 2015 Jan;38(1):105-7. doi: 10.1007/s40264-014-0254-8. No abstract available.

PMID:
25511912
19.

How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys.

Kessler RC, Rose S, Koenen KC, Karam EG, Stang PE, Stein DJ, Heeringa SG, Hill ED, Liberzon I, McLaughlin KA, McLean SA, Pennell BE, Petukhova M, Rosellini AJ, Ruscio AM, Shahly V, Shalev AY, Silove D, Zaslavsky AM, Angermeyer MC, Bromet EJ, de Almeida JM, de Girolamo G, de Jonge P, Demyttenaere K, Florescu SE, Gureje O, Haro JM, Hinkov H, Kawakami N, Kovess-Masfety V, Lee S, Medina-Mora ME, Murphy SD, Navarro-Mateu F, Piazza M, Posada-Villa J, Scott K, Torres Y, Carmen Viana M.

World Psychiatry. 2014 Oct;13(3):265-74. doi: 10.1002/wps.20150.

20.

Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis.

Iribarren C, Round AD, Peng JA, Lu M, Klatsky AL, Zaroff JG, Holve TJ, Prasad A, Stang P.

Ann Noninvasive Electrocardiol. 2014 Sep;19(5):490-500. doi: 10.1111/anec.12157. Epub 2014 May 14.

PMID:
24829126

Supplemental Content

Loading ...
Support Center